
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15527123
[patent_doc_number] => 20200055867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => SUBSTITUTED [5,6]CYCLIC-4(3H)-PYRIMIDINONES AS ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/487832
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487832 | Substituted [5,6]cyclic-4(3H)-pyrimidinones as anticancer agents | May 7, 2018 | Issued |
Array
(
[id] => 16777899
[patent_doc_number] => 20210114976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Stilbene Derivatives for the Treatment of CNS and Other Disorders
[patent_app_type] => utility
[patent_app_number] => 16/611945
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611945 | Stilbene derivatives for the treatment of CNS and other disorders | May 7, 2018 | Issued |
Array
(
[id] => 15102097
[patent_doc_number] => 10472348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Amide-substituted pyridinyltriazole derivatives and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/969222
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24727
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15969222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/969222 | Amide-substituted pyridinyltriazole derivatives and uses thereof | May 1, 2018 | Issued |
Array
(
[id] => 15614499
[patent_doc_number] => 20200077654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => Use of an Acyclic Picolinamide Compound as a Fungicide for Fungal Diseases on Turfgrasses
[patent_app_type] => utility
[patent_app_number] => 16/610097
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610097 | Use of an acyclic picolinamide compound as a fungicide for fungal diseases on turfgrasses | May 1, 2018 | Issued |
Array
(
[id] => 16009093
[patent_doc_number] => 20200179389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => NOVEL ALK2 INHIBITORS AND METHODS FOR INHIBITING BMP SIGNALING
[patent_app_type] => utility
[patent_app_number] => 16/608489
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -97
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608489
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608489 | ALK2 inhibitors and methods for inhibiting BMP signaling | Apr 25, 2018 | Issued |
Array
(
[id] => 13732983
[patent_doc_number] => 20180370959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => Liver X. Receptor (LXR) Modulators for the Treatment of Dermal Diseases, Disorders and Conditions
[patent_app_type] => utility
[patent_app_number] => 15/956389
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956389
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/956389 | Liver X. Receptor (LXR) Modulators for the Treatment of Dermal Diseases, Disorders and Conditions | Apr 17, 2018 | Abandoned |
Array
(
[id] => 17952368
[patent_doc_number] => 11478440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent
[patent_app_type] => utility
[patent_app_number] => 16/606233
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 16
[patent_no_of_words] => 18072
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606233
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606233 | Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent | Apr 17, 2018 | Issued |
Array
(
[id] => 16108293
[patent_doc_number] => 20200206169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => COMBINATION COMPRISING A PPAR AGONIST SUCH AS ELAFIBRANOR AND AN ACETYL-COA CARBOXYLASE (ACC) INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/606235
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606235
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606235 | Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor | Apr 17, 2018 | Issued |
Array
(
[id] => 13371745
[patent_doc_number] => 20180237413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/954759
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15954759
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/954759 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | Apr 16, 2018 | Abandoned |
Array
(
[id] => 16748773
[patent_doc_number] => 20210100782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => PARASITIC PEST CONTROL AGENTS COMPRISING PYRIDONE COMPOUNDS AS ACTIVE INGREDIENTS AND METHODS FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/497575
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 1154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497575
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497575 | Parasitic pest control agents comprising pyridone compounds as active ingredients and methods for using the same | Apr 9, 2018 | Issued |
Array
(
[id] => 13490023
[patent_doc_number] => 20180296554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => INHIBITORS OF THE FKBP51 PROTEIN FROM A HIGH-THROUGHPUT DRUG SCREEN AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/949703
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15949703
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/949703 | Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use | Apr 9, 2018 | Issued |
Array
(
[id] => 18202340
[patent_doc_number] => 11584722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/500774
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21070
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500774 | Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof | Apr 3, 2018 | Issued |
Array
(
[id] => 13342659
[patent_doc_number] => 20180222869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => ANTICANCER DRUGS INCLUDING THE CHEMICAL STRUCTURES OF AN ANDROGEN RECEPTOR LIGAND AND A HISTONE DEACETYLASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/944659
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944659
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/944659 | ANTICANCER DRUGS INCLUDING THE CHEMICAL STRUCTURES OF AN ANDROGEN RECEPTOR LIGAND AND A HISTONE DEACETYLASE INHIBITOR | Apr 2, 2018 | Abandoned |
Array
(
[id] => 15491571
[patent_doc_number] => 20200045974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => Substituted Oxadiazoles for Combating Phytopathogenic Fungi
[patent_app_type] => utility
[patent_app_number] => 16/500536
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500536
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500536 | Substituted Oxadiazoles for Combating Phytopathogenic Fungi | Mar 28, 2018 | Abandoned |
Array
(
[id] => 16635229
[patent_doc_number] => 10913724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Production method for amidate compound
[patent_app_type] => utility
[patent_app_number] => 16/497997
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14518
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497997
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497997 | Production method for amidate compound | Mar 28, 2018 | Issued |
Array
(
[id] => 15740559
[patent_doc_number] => 20200109167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => SMALL MOLECULE DCN1 INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/496974
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496974 | Small molecule DCN1 inhibitors and therapeutic methods using the same | Mar 27, 2018 | Issued |
Array
(
[id] => 15435219
[patent_doc_number] => 20200031793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => Synthesis of Thapsigargin, Nortrilobolide, and Analogs Thereof
[patent_app_type] => utility
[patent_app_number] => 16/496688
[patent_app_country] => US
[patent_app_date] => 2018-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496688 | Synthesis of thapsigargin, nortrilobolide, and analogs thereof | Mar 26, 2018 | Issued |
Array
(
[id] => 13314045
[patent_doc_number] => 20180208559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => PROCESS FOR THE PREPARATION OF 3-HALOALKYLPYRAZOLES
[patent_app_type] => utility
[patent_app_number] => 15/935528
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15935528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/935528 | PROCESS FOR THE PREPARATION OF 3-HALOALKYLPYRAZOLES | Mar 25, 2018 | Abandoned |
Array
(
[id] => 16969275
[patent_doc_number] => 11065221
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Buthionine sulfoximine and a metallodrug for the treatment of cancer, HIV or a rheumatic disease
[patent_app_type] => utility
[patent_app_number] => 16/496039
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8980
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496039 | Buthionine sulfoximine and a metallodrug for the treatment of cancer, HIV or a rheumatic disease | Mar 22, 2018 | Issued |
Array
(
[id] => 15360753
[patent_doc_number] => 20200016141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => INDAZOLE INHIBITORS OF FRUCTOKINASE (KHK) AND METHODS OF USE IN TREATING KHK-MEDIATED DISORDERS OR DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/494946
[patent_app_country] => US
[patent_app_date] => 2018-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494946 | Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases | Mar 18, 2018 | Issued |